التهاب الغدد العرقية المتقيح في مريض طفل أصغر من 18 عامًا

References

DOI: 10.1016/j.jaad.2019.02.067

Management strategies are similar to those for adults with some specific considerations outlined in Table VIII.

Clindamycin and rifampin in combination have been studied in HS more than most other antibiotics, typically with both used at a dose of 300 mg twice daily.

Adalimumab at the approved HS dosing is recommended to improve disease severity and quality of life in patients with moderate-to-severe HS.

Avoid tetracyclines in children younger than 9 years and acitretin in female patients during the childbearing years.